Month: May 2015
-
Eli Lilly Opening Drug Delivery, Device Research Center
6 May 2015. Pharmaceutical maker Eli Lilly and Company is opening a new research facility in Cambridge, Massachusetts concentrating on drug delivery and medical devices. The research center, in Cambridge’s Kendall Square, is expected to open by the end of 2015 and hire some 30 scientists and engineers. The need for innovation in drug delivery…
-
New Company Founded to Develop Centimeter-Accurate GPS
Video: Centimeter-level GPS used in a virtual reality headset (University of Texas, Austin) 6 May 2015. An engineering lab at University of Texas in Austin designed a low-cost portable global positioning system with precision to a few centimeters, and started a company to take the technology to market. A team from UT-Austin’s Radionavigation Laboratory, led…
-
23andMe, Lupus Institute Partner on Genetics Study
5 May 2015. The personal genetics company 23 andMe and Lupus Research Institute are collaborating on a study of genetic associations with systemic lupus erythematosus, the disease more commonly known as lupus. Financial and intellectual property details of the collaboration between 23andMe, Lupus Research Institute, and Pfizer Inc. serving as an adviser to the project,…
-
Trial Underway Testing RNA Therapy for Rare Liver Disorder
5 May 2015. An early-stage clinical trial is testing a therapy derived from genetic material to treat alpha-1 antitrypsin deficiency, a rare inherited disease affecting the liver and lungs. The therapy, code-named ARC-AAT, is developed by Arrowhead Research Corporation, a biopharmaceutical company in Pasadena, California. Alpha-1 antitrypsin deficiency, or AATD, is caused by a mutation…
-
Cancer Therapy Spin-Off Gets $2M Small Business Grant
4 May 2015. A three year-old company started by a University at Buffalo microbiologist received a $2 million grant to develop an antibody into a clinical treatment for breast and other types of cancer. For-Robin in Williamsville, New York, received the two-year award from National Cancer Institute, part of National Institutes of Health, under the…
-
Stem Cells Treat Vision Disorders in Animal Tests
4 May 2015. Tests with lab rats of a therapy for degenerating retinas in the eyes, show the treatments derived from human embryonic stem cells can restore visual functions. Results of the treatments, developed by Cell Cure Neurosciences Ltd., are scheduled to be reported today by a research team from Oregon Health and Science University…
-
Heart Drug Developer Raises $46M in Venture Funds
1 May 2015. MyoKardia Inc., a developer of therapies for inherited heart diseases, raised $46 million in its second venture funding round. Taking part in the financing for the South San Francisco, California company are the drug company Sanofi that already holds an equity stake in MyoKardia, as well as venture capital firms Casdin Capital,…
-
Robotic Exoskeleton Developed for Upper-Body Rehab
1 May 2015. A robotic device that helps recover upper-body functions for people with neurological or spinal injuries is being developed by engineers at University of Texas in Austin. Developers of the exoskeleton, called Harmony, plan clinical trials of the device later in 2015. Harmony is a project of UT-Austin’s Rehabilitation and Neuromuscular Robotics Laboratory…